Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Built on Snowflake Cortex AI, the agent enables representatives to generate comprehensive pre-call plans through a single conversational interface
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms
Based in the global marketing function, he will be responsible for strengthening the company's visibility among sponsors, partners and industry stakeholders worldwide
Ariane brings a strong track record within Ardena, including her leadership of the company’s drug product division since 2022
Subscribe To Our Newsletter & Stay Updated